Maartje Blom

431 total citations
16 papers, 245 citations indexed

About

Maartje Blom is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Maartje Blom has authored 16 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Genetics. Recurrent topics in Maartje Blom's work include Immunodeficiency and Autoimmune Disorders (14 papers), Cystic Fibrosis Research Advances (10 papers) and Blood disorders and treatments (5 papers). Maartje Blom is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (14 papers), Cystic Fibrosis Research Advances (10 papers) and Blood disorders and treatments (5 papers). Maartje Blom collaborates with scholars based in Netherlands, United Kingdom and United States. Maartje Blom's co-authors include Mirjam van der Burg, Robbert G. M. Bredius, Peter C. J. I. Schielen, C.P.B. van der Ploeg, M. Elske van den Akker‐van Marle, Joris M. van Montfrans, Martine C. de Vries, Ingrid Pico‐Knijnenburg, Mariëlle van Gijn and Taco W. Kuijpers and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Allergy and Clinical Immunology.

In The Last Decade

Maartje Blom

15 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maartje Blom Netherlands 11 165 105 82 51 45 16 245
Nikita Raje United States 9 94 0.6× 47 0.4× 51 0.6× 50 1.0× 10 0.2× 19 224
Nermeen Galal Egypt 11 243 1.5× 94 0.9× 54 0.7× 70 1.4× 11 0.2× 34 310
Savaş Kansoy Türkiye 10 43 0.3× 50 0.5× 25 0.3× 48 0.9× 68 1.5× 18 219
Zoe Allwood United Kingdom 4 210 1.3× 76 0.7× 68 0.8× 58 1.1× 14 0.3× 5 226
Tal Ben‐Ami Israel 10 49 0.3× 43 0.4× 34 0.4× 24 0.5× 14 0.3× 25 268
Irina A. Tuzankina Russia 8 60 0.4× 44 0.4× 55 0.7× 26 0.5× 5 0.1× 45 196
Giorgia Bucciol Belgium 9 148 0.9× 63 0.6× 36 0.4× 53 1.0× 9 0.2× 15 226
Andrea Martín-Nalda Spain 7 101 0.6× 51 0.5× 38 0.5× 36 0.7× 9 0.2× 10 139
Coralie Briand France 6 50 0.3× 17 0.2× 39 0.5× 19 0.4× 12 0.3× 9 163
Shannon Brothers New Zealand 7 82 0.5× 33 0.3× 46 0.6× 23 0.5× 5 0.1× 11 138

Countries citing papers authored by Maartje Blom

Since Specialization
Citations

This map shows the geographic impact of Maartje Blom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maartje Blom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maartje Blom more than expected).

Fields of papers citing papers by Maartje Blom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maartje Blom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maartje Blom. The network helps show where Maartje Blom may publish in the future.

Co-authorship network of co-authors of Maartje Blom

This figure shows the co-authorship network connecting the top 25 collaborators of Maartje Blom. A scholar is included among the top collaborators of Maartje Blom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maartje Blom. Maartje Blom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Berghuis, Dagmar, et al.. (2025). Clinical challenges following early detection of ataxia telangiectasia through SCID newborn screening. SHILAP Revista de lepidopterología. 1(4).
2.
Blom, Maartje, Pere Soler‐Palacín, Anna Šedivá, et al.. (2024). Newborn screening for SCID and severe T lymphocytopenia in Europe. Journal of Allergy and Clinical Immunology. 155(2). 377–386. 5 indexed citations
3.
Bekker, Vincent, et al.. (2023). Epigenetic Immune Cell Counting to Analyze Potential Biomarkers in Preterm Infants: A Proof of Principle in Necrotizing Enterocolitis. International Journal of Molecular Sciences. 24(3). 2372–2372. 2 indexed citations
4.
Blom, Maartje, et al.. (2023). Efficient screening strategies for severe combined immunodeficiencies in newborns. Expert Review of Molecular Diagnostics. 23(9). 815–825. 1 indexed citations
5.
Marle, M. Elske van den Akker‐van, Maartje Blom, Mirjam van der Burg, Robbert G. M. Bredius, & C.P.B. van der Ploeg. (2021). Economic Evaluation of Different Screening Strategies for Severe Combined Immunodeficiency Based on Real-Life Data. International Journal of Neonatal Screening. 7(3). 60–60. 6 indexed citations
7.
Blom, Maartje, Rolf Zetterström, Asbjørg Stray‐Pedersen, et al.. (2021). Recommendations for uniform definitions used in newborn screening for severe combined immunodeficiency. Journal of Allergy and Clinical Immunology. 149(4). 1428–1436. 22 indexed citations
8.
Dijk, Tessa van, Marleen E. Jansen, Wybo Dondorp, et al.. (2021). Expanding Neonatal Bloodspot Screening: A Multi-Stakeholder Perspective. Frontiers in Pediatrics. 9. 706394–706394. 15 indexed citations
9.
Blom, Maartje, Robbert G. M. Bredius, & Mirjam van der Burg. (2021). Future Perspectives of Newborn Screening for Inborn Errors of Immunity. International Journal of Neonatal Screening. 7(4). 74–74. 11 indexed citations
10.
Blom, Maartje, Robbert G. M. Bredius, Marleen E. Jansen, et al.. (2020). Parents’ Perspectives and Societal Acceptance of Implementation of Newborn Screening for SCID in the Netherlands. Journal of Clinical Immunology. 41(1). 99–108. 29 indexed citations
11.
Montfrans, Joris M. van, Mariëlle van Gijn, Maartje Blom, et al.. (2020). Cost and impact of early diagnosis in primary immunodeficiency disease: A literature review. Clinical Immunology. 213. 108359–108359. 33 indexed citations
12.
Blom, Maartje, Martine C. de Vries, Corry M.R. Weemaes, et al.. (2019). Dilemma of Reporting Incidental Findings in Newborn Screening Programs for SCID: Parents’ Perspective on Ataxia Telangiectasia. Frontiers in Immunology. 10. 2438–2438. 20 indexed citations
13.
Blom, Maartje, et al.. (2019). Early diagnosis of ataxia telangiectasia in the neonatal phase: a parents’ perspective. European Journal of Pediatrics. 179(2). 251–256. 14 indexed citations
14.
Ploeg, C.P.B. van der, Maartje Blom, Robbert G. M. Bredius, et al.. (2019). Cost-effectiveness of newborn screening for severe combined immunodeficiency. European Journal of Pediatrics. 178(5). 721–729. 24 indexed citations
15.
Blom, Maartje, Robbert G. M. Bredius, Eugènie Dekkers, et al.. (2018). Introducing Newborn Screening for Severe Combined Immunodeficiency (SCID) in the Dutch Neonatal Screening Program. International Journal of Neonatal Screening. 4(4). 40–40. 21 indexed citations
16.
Blom, Maartje, Ingrid Pico‐Knijnenburg, Anita Boelen, et al.. (2017). An evaluation of the TREC assay with regard to the integration of SCID screening into the Dutch newborn screening program. Clinical Immunology. 180. 106–110. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026